SARS-CoV-2 Alpha Variant Infection of a Patient Immunized by Inactive Sinovac (CoronaVac) Vaccine [PDF]
, 2022 Cenk Serhan Özverel +6 more
openalex +1 more source
Tuberculosis Trends in the Post‐COVID‐19 Era: Is It Going to be a Global Concern?
Health Science Reports, Volume 8, Issue 5, May 2025.ABSTRACT Background and Aims Tuberculosis (TB), a leading cause of death from infectious diseases, faced considerable challenges during the coronavirus disease 2019 (COVID‐19) pandemic. This review examines the impact of pandemic‐related disruptions, including the diversion of healthcare resources, reduced access to TB diagnostics and treatment, and ...
Soroush Khojasteh‐Kaffash +5 more
wiley +1 more source
Clinical Case Reports, Volume 13, Issue 4, April 2025.ABSTRACT Fulminant type 1 diabetes is a rare but severe condition that can develop rapidly, often in association with viral infections. In this case, coxsackievirus B6 antibody levels were elevated after disease onset, though its significance remains unclear.
Hisaka Minami +10 more
wiley +1 more source
Two-dose Covid-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong [PDF]
, 2021 Objectives: To investigate the relationship between COVID-19 full vaccination (two completed doses) and possible arthritis flare. Methods: Patients with rheumatoid arthritis (RA) were identified from population-based electronic medical records with ...
Chan, EWY +11 more
core
Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety
Clinical and Translational Allergy, Volume 15, Issue 3, March 2025.Abstract Background COVID‐19 exhibits a variety of symptoms and may lead to multi‐organ failure and death. This clinical complexity is exacerbated by significant immune dysregulation affecting nearly all cells of the innate and adaptive immune system. Granulocytes, including eosinophils, are affected by SARS‐CoV‐2.
Wided Sahli, Joana Vitte, Benoit Desnues
wiley +1 more source
Serological assays for differentiating natural COVID-19 infection from vaccine induced immunity [PDF]
BACKGROUND: Natural SARS-CoV-2 infection may elicit antibodies to a range of viral proteins including non-structural protein ORF8. RNA, adenovirus vectored and sub-unit vaccines expressing SARS-CoV-2 spike would be only expected to elicit S-antibodies ...
Amarasinghe, Gaya K +2 more
core +2 more sources
The FEBS Journal, Volume 292, Issue 6, Page 1480-1499, March 2025.Vaccination plays a crucial role in mediating protection against infectious diseases, but immune responses to vaccination are highly variable and frequently sub‐optimal in vulnerable populations. Here, we review the latest preclinical and clinical evidence demonstrating that the gut microbiota plays a significant role in regulating immune responses to ...
Charné Rossouw +2 more
wiley +1 more source
SARS‐CoV‐2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two‐dose CoronaVac vaccine regimen [PDF]
Journal of Medical Virology, 2021 Ali Umit, Keskin +3 more
openaire +2 more sources
Humoral Response to BNT162b2 and CoronaVac in Patients Undergoing Maintenance Hemodialysis: A Multicenter Prospective Cohort Study. [PDF]
, 2023 Alagoz S. +10 more
core +2 more sources
ESC Heart Failure, Volume 12, Issue 1, Page 338-352, February 2025.Abstract Aims Acute myocarditis (AM) has been recognized as a rare complication of coronavirus disease 2019 (COVID‐19) infection. This study was conducted to present the clinical characteristics, disease courses and short‐term prognoses of Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) induced AM in China, which has ...
Huihui Liu +17 more
wiley +1 more source